Results 251 to 260 of about 2,203,706 (318)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Bridging language and data: Transforming agricultural curricula for data analytics through linguistic insights. [PDF]

open access: yesPLoS One
Xu Z   +7 more
europepmc   +1 more source

A faculty-wide "Night of Skills" to (not only) train medical skills: comprehensive evaluation study. [PDF]

open access: yesBMC Med Educ
Mahling M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy